Merus
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.About MRUS
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.
MRUS Key Statistics
MRUS News
William Blair downgraded Merus (MRUS) to Market Perform from Outperform after the company agreed to be acquired by Genmab (GMAB) for $97 per share in cash. Ele...
Genmab A/S (NASDAQ: GMAB) on Monday agreed to acquire Merus N.V. (NASDAQ: MRUS) with its late-stage asset petosemtamab, which is in Phase 3 development, for $97...
Merus surges after Genmab says it will acquire it for $8 billion Danish biotech Genmab announced on Monday that it will acquire cancer startup Merus in an all-...
Analyst ratings
94%
of 18 ratingsMore MRUS News
In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Bicara Therapeutics Inc., with a price target of $22.00. Elevate Your Invest...
In a report released today, Evan Seigerman from BMO Capital maintained a Buy rating on Merus, with a price target of $110.00. Elevate Your Investing Strategy: T...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
...
